For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Cell Genesys, Inc.

USPTO Granted Patents = 78

% Expired Patents = 25.6

CIPO Patents = 2

EPO Patents = 1

Forward Citations = 3,124

Loading Chart...

Loading Chart...

94 inventors (with patents filed for the assignee):

Deborah A Farson (16 out of 18 patents)

Daniel R Henderson (16 out of 30 patents)

Thomas L Dull (12 out of 15 patents)

4. De-Chao Yu (11 out of 14 patents)

5. Margo R Roberts (11 out of 13 patents)

6. Mitchell H Finer (10 out of 12 patents)

7. Daniel J Capon (9 out of 32 patents)

8. Krisztina M Zsebo (9 out of 30 patents)

9. Yuanhao Li (8 out of 9 patents)

10. Luigi Naldini (7 out of 9 patents)

11. Rochelle Witt (6 out of 8 patents)

12. Eric R Schuur (6 out of 13 patents)

13. James G McArthur (5 out of 11 patents)

14. DeChao Yu (5 out of 6 patents)

15. De Chao Yu (5 out of 6 patents)

Core Competencies:

Adenoviral Vectors

Lentivirus Production

Cancer-Specific Promoters

Gene Manipulation

Immunoglobulin Expression

Oncolytic Vectors

Transduction Enhancement

Transcriptional Enhancers

Chimeric Receptors

Retroviral Vectors

Viral Gene Therapy

Cell-Specific Delivery

78 patents: Sort by Forward Citations

1. 7575919 - Adenovirus vectors containing cell status-specific response elements and methods of use thereof (2009-08-18),

2. 7498024 - Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site (2009-03-03),

3. 7485291 - Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof (2009-02-03),

4. 7482156 - Hepatocellular carcinoma specific promoter and uses thereof (2009-01-27),

5. 7473418 - Pan cancer oncolytic vectors and methods of use thereof (2009-01-06),

6. 7459154 - Methods and reagents for the enhancement of virus transduction in the bladder epithelium (2008-12-02),

7. 7371570 - Cell-specific adenovirus vector comprising EBV-specific promoter (2008-05-13),

8. 7364727 - Metastatic colon cancer specific promoter and uses thereof (2008-04-29),

9. 7319033 - Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof (2008-01-15),

10. 7276233 - Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy (2007-10-02),

11. 7267815 - Methods and reagents for the enhancement of virus transduction in the bladder epithelium (2007-09-11),

12. 7252991 - Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells (2007-08-07),

13. 7250299 - Method and means for producing high titer, safe, recombinant lentivirus vectors (2007-07-31),

14. 7226606 - Cancer-associated antigens and methods of their identification and use (2007-06-05),

15. 7217421 - Cancer-associated antigens and methods of their identification and use (2007-05-15),

Cell Genesys, Inc. is a biotechnology company based in South San Francisco, California, specializing in gene therapy technologies. The company focuses on the development and production of innovative therapeutic solutions utilizing adenoviral and lentiviral vectors. Its research encompasses cancer-specific promoters, gene manipulation techniques, and oncolytic vectors, aimed at enhancing transduction and immunoglobulin expression. Cell Genesys is dedicated to advancing the field of gene therapy to address unmet medical needs in oncology and other therapeutic areas.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

78 Patents

#16 in South San Francisco, CA

#1,097 in California

#4,736 in US

#9,661 in the World

South San Francisco, CA, United States of America

Cell Genesys, Inc.

Forward Citations = 3,124

94 inventors:

Deborah A Farson (16 out of 18 patents)

Daniel R Henderson (16 out of 30 patents)

Thomas L Dull (12 out of 15 patents)

4. De-Chao Yu (11 out of 14 patents)

5. Margo R Roberts (11 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…